Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating activities:
Net loss	$ (4,420,500)	$ (3,287,026)
Adjustments to reconcile net loss to cash used in operating activities:
Provision for uncollectable accounts receivable	0	4,281
Amortization and depreciation	97,699	119,539
Non-cash issuance of stock options	308,095	199,429
Amortization of derivative and warrant liabilities discount	453,838	1,020,365
Amortization of deferred debt issuance costs and original issue discount	112,574	391,072
Change in fair value of derivative and warrant liabilities	2,051,760	83,198
Loss on extinguishment of debt	0	16,989
Fair market value of common stock issued for debt offering costs	50,000	244,500
Changes in assets and liabilities:
Accounts receivable	60,000	(124,281)
Inventory	(68,729)	58,114
Prepaid expenses and other current assets	39,211	42,594
Accounts payable	(31,894)	194,954
Accrued expenses	196,412	258,914
Net cash used in operating activities	(1,151,534)	(777,358)
Investing activities:
Purchases of fixed assets	(6,275)	0
Net cash used in investing activities	(6,275)	0
Financing activities:
Proceeds from issuance of convertible notes payable	1,506,376	862,000
Payments against note payable to affiliate	(30,000)	0
Proceeds from exercise of stock options	18,624	0
Debt issuance costs	(130,000)	(169,440)
Net cash provided by financing activities	1,365,000	692,560
Net increase (decrease) in cash	207,191	(84,798)
Cash, beginning of year	236,597	90,192
Cash, end of period	443,788	5,394
Supplemental Disclosure of Cash Flow Information:
Interest	0	0
Income taxes	0	0
Non Cash Investing and Financing Activities:
Conversion of convertible notes to common stock	0	263,157
Conversion of interest due on convertible notes to common stock	0	33,988
Exchange of interest due on convertible notes to new notes	0	25,259
Conversion of preferred stock to common stock	0	5,000
Warrant valuation on issuance of convertible debentures	$ 806,924	$ 0